It develops Etigilimab (MPH-313), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumors. Receive News & Ratings for Mereo ...

The finance round was led by OrbiMed and comes almost exactly two years after Mereo decided to pull a US IPO, blaming challenging market conditions. In the phase 1b combination study, a total of ...

This is the story: It was 1982. Mark Tronson, a young Baptist minister was serving two days a week with the InterChurch Trade and Industry Mission (ITIM) as the industrial padre at Shell Australia's ...

Returning from the 1982 Hong Kong conference on sports ministry I submitted reports to my own Baptist authorities and ITIM – as a consequence Heads of Churches adopted the sports chaplaincy ministry ...

After hours: March 21 at 6:05:08 PM EDT Loading Chart for MREO ...